Authors: BIEWENGA GP VEENINGGRIFFIOEN DH NICASTIA AJ HAENEN GRMM BAST A

Citation: Gp. Biewenga et al., EFFECTS OF DIHYDROLIPOIC ACID ON PEPTIDE METHIONINE SULFOXIDE REDUCTASE - IMPLICATIONS FOR ANTIOXIDANT DRUGS, Arzneimittel-Forschung, 48(2), 1998, pp. 144-148

Authors: BIEWENGA GP HAENEN GRMM GROEN BH BIEWENGA JE VANGRONDELLE R BAST A

Citation: Gp. Biewenga et al., COMBINED NONENZYMATIC AND ENZYMATIC REDUCTION FAVORS BIOACTIVATION OFRACEMIC LIPOIC ACID - AN ADVANTAGE OF A RACEMIC DRUG, Chirality, 9(4), 1997, pp. 362-366

Authors: BIEWENGA GP HAENEN GRMM BAST A

Citation: Gp. Biewenga et al., THE ROLE OF LIPOIC ACID IN THE TREATMENT OF DIABETIC POLYNEUROPATHY, Drug metabolism reviews, 29(4), 1997, pp. 1025-1054

Authors: BIEWENGA GP HAENEN GRMM BAST A

Citation: Gp. Biewenga et al., THE PHARMACOLOGY OF THE ANTIOXIDANT LIPOIC ACID, General pharmacology, 29(3), 1997, pp. 315-331

Authors: BIEWENGA GP DORSTIJN MA VERHAGEN JV HAENEN GRMM BAST A

Citation: Gp. Biewenga et al., REDUCTION OF LIPOIC ACID BY LIPOAMIDE DEHYDROGENASE, Biochemical pharmacology, 51(3), 1996, pp. 233-238

Authors: BIEWENGA GP DEJONG J BAST A

Citation: Gp. Biewenga et al., LIPOIC ACID FAVORS THIOLSULFINATE FORMATION AFTER HYPOCHLOROUS ACID SCAVENGING - A STUDY WITH LIPOIC ACID-DERIVATIVES, Archives of biochemistry and biophysics, 312(1), 1994, pp. 114-120